journal article·2018-11-05Open access

The role of microRNAs and nanoparticles in ovarian cancer: a review

Leila Kafshdooz, Hojjat Pourfathi, Abolfazl Akbarzadeh, Taiebeh Kafshdooz, Zohre Razban, Roghayeh Sheervalilou, Naser Ebrahimi Sadr, Rovshan Khalilov, Siamak Saghfi, Taras Kavetskyy, Lala Mammadova, Masoud Mehrizadeh, Samaneh Ghasemali

Abstract

MicroRNAs (miRNAs) have had a revolutionary impact on cancer research over the recent years. They emerge as important players in tumourigenesis, leading to a paradigm shift in oncology. Ovarian cancer is the leading cause of death among gynaecologic malignancies. Therefore, there is a strong need for prognostic and predictive markers for early diagnosis which helps optimize and personalize treatment. Asymptomatically, ovarian cancer is often diagnosed at advanced and incurable stages. Efficient targeting and sustained release of miRNAs/anti-miRNAs using nanoparticles conjugated with antibodies and/or peptides could reduce the required therapeutic dosage while minimizing systemic and cellular toxicity. Given miRNAs importance in clinical oncology, here we focus on the development of miRNA nanoformulations to achieve enhanced cellular uptake, bioavailability and accumulation at the tumour site. Although many obstacles need to be overcome, miRNA therapy could be a powerful tool for ovarian cancer prevention and treatment. In this review, we discuss about the emerging roles of miRNAs in various aspects of ovarian cancer.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: MicroRNA in disease regulation · Circular RNAs in diseases · Extracellular vesicles in disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Medical Genetics, Women’s Reproductive Health Research Center, Tabriz, Iran;

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran;

Department of Anesthesiology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran;

Tuberculosis and Lung Disease Research Center of Tabriz, Tabriz University of Medical Sciences, Tabriz, Iran;

Department of Chemical Engineering, Northeastern University, Boston, MA, USA;

Universal Scientific Education and Research Network (USERN), Tabriz, Iran;

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran;

Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran;

Department of Public Health, Iran Veterinary Organization, Tabriz, Iran;

Joint Ukraine-Azerbaijan International Research and Education Center of Nanobiotechnology and Functional Nanosystems, Drohobych Ukraine & Baku, Azerbaijan;

Department of Plant Physiology, Faculty of Biology, Baku State University, Baku, Azerbaijan;

The John Paul II Catholic University of Lublin, Lublin, Poland;

Drohobych Ivan Franko State Pedagogical University, Drohobych, Ukraine;

Department of Biophysics and Molecular Biology, Baku State University, Baku, Azerbaijan;

Department of Petroleum Engineering, School of Engineering and Applied Sciences, Khazar University, Baku, Azerbaijan

Funding

Tabriz University of Medical Sciences

References (83)

Show source-provided references
1. 10.4103/0975-7406.7212710.4103/0975-7406.72127 ↗
2. 10.1016/j.ctrv.2012.07.00510.1016/j.ctrv.2012.07.005 ↗
3. 10.3322/caac.2126210.3322/caac.21262 ↗
4. 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S ↗
5. 10.1016/j.medici.2014.09.00110.1016/j.medici.2014.09.001 ↗
6. 10.1002/cncr.2986910.1002/cncr.29869 ↗
7. 10.1016/S0140-6736(13)62146-710.1016/S0140-6736(13)62146-7 ↗
8. 10.1038/nrc314410.1038/nrc3144 ↗
9. 10.1242/jcs.07222310.1242/jcs.072223 ↗
10. 10.1038/nrc401910.1038/nrc4019 ↗
11. 10.1146/annurev-pathol-012513-10471510.1146/annurev-pathol-012513-104715 ↗
12. 10.1038/nrclinonc.2014.510.1038/nrclinonc.2014.5 ↗
13. 10.1016/0092-8674(93)90529-Y10.1016/0092-8674(93)90529-Y ↗
14. 10.1261/rna.218380310.1261/rna.2183803 ↗
15. 10.1093/nar/gkj11210.1093/nar/gkj112 ↗
16. 10.1186/1479-7364-5-2-9010.1186/1479-7364-5-2-90 ↗
17. 10.1038/nature0287110.1038/nature02871 ↗
18. 10.1038/nrg293610.1038/nrg2936 ↗
19. 10.1152/physrev.00006.201010.1152/physrev.00006.2010 ↗
20. 10.1093/nar/gkh02310.1093/nar/gkh023 ↗
21. 10.1371/journal.pcbi.003003710.1371/journal.pcbi.0030037 ↗
22. 10.1158/0008-5472.CAN-07-105810.1158/0008-5472.CAN-07-1058 ↗
23. 10.1038/nature0287310.1038/nature02873 ↗
24. 10.1093/nar/gkr33010.1093/nar/gkr330 ↗
25. 10.1126/science.122582910.1126/science.1225829 ↗
26. 10.1080/21691401.2017.130720810.1080/21691401.2017.1307208 ↗
27. 10.1016/j.biocel.2012.02.00410.1016/j.biocel.2012.02.004 ↗
28. 10.1586/erm.09.5710.1586/erm.09.57 ↗
29. 10.1080/21691401.2017.138974610.1080/21691401.2017.1389746 ↗
30. 10.1016/j.cell.2005.01.01410.1016/j.cell.2005.01.014 ↗
31. 10.1186/1476-4598-8-1710.1186/1476-4598-8-17 ↗
32. 10.1111/j.1582-4934.2009.00705.x10.1111/j.1582-4934.2009.00705.x ↗
33. 10.1677/ERC-09-009610.1677/ERC-09-0096 ↗
34. 10.1080/21691401.2017.128249610.1080/21691401.2017.1282496 ↗
35. 10.1038/s41598-017-18521-510.1038/s41598-017-18521-5 ↗
36. 10.1016/j.molcel.2007.05.01010.1016/j.molcel.2007.05.010 ↗
37. 10.1016/j.molcel.2007.05.01710.1016/j.molcel.2007.05.017 ↗
38. 10.1182/blood-2009-06-22921110.1182/blood-2009-06-229211 ↗
39. 10.3109/21691401.2014.94464610.3109/21691401.2014.944646 ↗
40. 10.1155/2014/24939310.1155/2014/249393 ↗
41. 10.1158/2159-8290.CD-12-009510.1158/2159-8290.CD-12-0095 ↗
42. 10.1016/j.canlet.2013.11.00410.1016/j.canlet.2013.11.004 ↗
43. 10.1016/j.ygyno.2009.05.02210.1016/j.ygyno.2009.05.022 ↗
44. 10.1111/aogs.1288310.1111/aogs.12883 ↗
45. 10.1016/j.critrevonc.2011.03.01010.1016/j.critrevonc.2011.03.010 ↗
46. 10.1371/journal.pone.005822610.1371/journal.pone.0058226 ↗
47. 10.1038/nature1016610.1038/nature10166 ↗
48. Tabrizi MHN · Iran Polym J · 1996 · 5 · 243
49. 10.1016/j.ygyno.2014.03.57510.1016/j.ygyno.2014.03.575 ↗
50. 10.1186/s12943-016-0536-010.1186/s12943-016-0536-0 ↗
51. 10.2147/nano.2006.1.4.53510.2147/nano.2006.1.4.535 ↗
52. 10.7314/APJCP.2013.14.2.105710.7314/APJCP.2013.14.2.1057 ↗
53. 10.1177/030006051347575910.1177/0300060513475759 ↗
54. 10.1038/bjc.2013.79510.1038/bjc.2013.795 ↗
55. 10.1038/bjc.2015.34010.1038/bjc.2015.340 ↗
56. 10.1007/s13277-015-3191-y10.1007/s13277-015-3191-y ↗
57. 10.1093/carcin/bgu13010.1093/carcin/bgu130 ↗
58. 10.1371/journal.pone.000531110.1371/journal.pone.0005311 ↗
59. 10.1371/journal.pone.002250810.1371/journal.pone.0022508 ↗
60. 10.1016/j.canlet.2016.12.01710.1016/j.canlet.2016.12.017 ↗
61. 10.1158/1078-0432.CCR-07-173110.1158/1078-0432.CCR-07-1731 ↗
62. 10.1007/s00428-010-1030-510.1007/s00428-010-1030-5 ↗
63. 10.1371/journal.pone.000731410.1371/journal.pone.0007314 ↗
64. 10.1073/pnas.080161510510.1073/pnas.0801615105 ↗
65. 10.1016/j.phrs.2004.08.00610.1016/j.phrs.2004.08.006 ↗
66. 10.1093/annonc/mdw00710.1093/annonc/mdw007 ↗
67. 10.1021/acs.nanolett.7b0292910.1021/acs.nanolett.7b02929 ↗
68. 10.3892/or.2015.393710.3892/or.2015.3937 ↗
69. 10.1016/j.matchemphys.2015.05.01710.1016/j.matchemphys.2015.05.017 ↗
70. 10.18632/oncotarget.576610.18632/oncotarget.5766 ↗
71. 10.7150/thno.1154310.7150/thno.11543 ↗
72. 10.18632/oncotarget.647610.18632/oncotarget.6476 ↗
73. 10.3109/21691401.2014.97180710.3109/21691401.2014.971807 ↗
74. 10.3109/21691401.2015.102962510.3109/21691401.2015.1029625 ↗
75. 10.1016/j.biomaterials.2012.12.01510.1016/j.biomaterials.2012.12.015 ↗
76. 10.4028/www.scientific.net/AMR.829.68310.4028/www.scientific.net/AMR.829.683 ↗
77. 10.4161/rna.8.5.1615410.4161/rna.8.5.16154 ↗
78. 10.1021/ac500173d10.1021/ac500173d ↗
79. 10.1158/0008-5472.CAN-11-316010.1158/0008-5472.CAN-11-3160 ↗
80. 10.1038/onc.2014.46910.1038/onc.2014.469 ↗
81. 10.1158/2159-8290.CD-13-015910.1158/2159-8290.CD-13-0159 ↗
82. 10.1111/apm.1251410.1111/apm.12514 ↗
83. 10.1016/j.biopha.2016.09.08710.1016/j.biopha.2016.09.087 ↗